Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: Evidence for TRAIL induction via the T cell receptor signaling pathway

Experimental Cell Research

Volumn 252, Issue 1, 1999, Pages 96-103

  Musgrave, Bruce L ^a   Phu, Tom ^a   Butler, Jared J ^a   Makrigiannis, Andrew P ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Gene expression; Signal transduction; T cell receptor; T lymphocyte; TRAIL

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALPHOSTIN C; CD28 ANTIGEN; CYCLOSPORIN A; GENISTEIN; HERBIMYCIN A; INTERLEUKIN 2 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; STAUROSPORINE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE INDUCTION; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

EID: 0033543986     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4631     Document Type: Article

References (41)

1. Wiley S. R., Schooley K., Smolak P. J., Din W. S., Huang C.-P., Nicholl J. K., Sutherland G. R., Smith T. D., Rauch C., Smith C. A., Goodwin R. G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682.
2. Griffith T. S., Lynch D. H. TRAIL: A molecule with multiple receptors and control mechanisms. Curr. Opinion Immunol. 10:1998;559-563.
3. Pitti R. M., Marsters S. A., Rupper S., Donahue C. J., Moore A., Ashkenazi A. Induction of apoptosis by APO-2 ligand, a new member of the TNF cytokine family. J. Biol. Chem. 271:1996;12687-12690.
4. Pan G., O'Rourke K., Chinnaiyan A. M., Gentz R., Schoenfeld H.-J., Broger C., Loetscher H., Lesslauer W. The receptor for the cytotoxic ligand TRAIL. Science. 276:1997;111-113.
5. Pan G., Ni J., Wei Y.-f., Yu G. I., Gentz R., Dixit V. M. An antagonistic decoy receptor and a death domain-containing receptor for TRAIL. Science. 277:1997;815-818.
6. Degli-Esposti M. A., Dougall W. C., Smolak P. J., Waugh J. Y., Smith C. A., Goodwin R. G. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity. 7:1997;813-820.
7. Schneider P., Thome M., Burns K., Bodmer J.-L., Hofmann K., Kataoka T., Holler N., Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity. 7:1997;831-836.
8. Griffith T. S., Chin W. A., Jackson G. C., Lynch D. H., Kubin M. Z. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161:1998;2833-2840.
9. Mariani S. M., Krammer P. H. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur. J. Immunol. 28:1998;973-982.
10. Mariani S. M., Krammer P. H. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur. J. Immunol. 28:1998;1492-1498.
11. Jeremias I., Herr I., Boehler T., Debatin K.-M. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28:1998;143-152.
12. Zamai L., Ahmad M., Bennet I. M., Azzoni L., Alnemri E. S., Perussia B. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188:1998;2375-2380.
13. Thomas W. D., Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J. Immunol. 161:1998;2195-2200.
14. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:1973;645-649.
15. Leo O., Foo M., Sachs D. H., Samelson L. E., Bluestone J. A. Identification of a monoclonal antibody specific to a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1987;1374-1378.
16. Singer-Sam J., Robinson M. O., Bellvè, Simon M. I., Riggs A. P. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, Mtase and Zyf gene transcripts during mouse spermatogenesis. Nucleic Acids Res. 18:1990;1255-1259.
17. Weiss A., Littman D. R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
18. Akiyama T., Ishada J., Nakagawa S., Ogawara H., Watanabe S. I., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
19. June C. H., Fletcher M. C., Ledbetter J. A., Schieven G. L., Siegel J. N., Phillips A. F., Samelson L. E. Inhibition of tyrosine phosporylation prevents T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA. 87:1990;7722-7726.
20. Stewart B. H., Hoskin D. W. Inhibition of protein tyrosine kinases or protein kinase C prevents nonspecific killer T lymphocyte-mediated tumoricidal activity. Biochim. Biophys. Acta. 1356:1997;333-342.
21. Nakanishi S., Catt K. J., Balla T. A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc. Natl. Acad. Sci. USA. 92:1995;5317-5321.
22. Vlahos C. J., Matter W. F., Hui K. Y., Brown R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
23. Ward S. G., June C. H., Olive D. PI 3-kinase: A pivotal pathway in T-cell activation. Immunol. Today. 17:1996;187-197.
24. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:1989;548-553.
25. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Norimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca2+ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:1986;397-402.
26. Clipstone N. A., Crabtree G. R. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature. 357:1992;695-697.
27. Anel A., Buferne M., Boyer C., Schmitt-Verhulst A.-M., Golstein P. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24:1994;2469-2476.
28. Kaiser M., Brooks-Kaiser J., Fitzpatrick L., Bleackley R. C., Hoskin D. W. Cytotoxic cell proteinase gene expression and cytolytic activity by anti-CD3-activated cytotoxic T lymphocytes is sensitive to cyclosporin a but is not dependent on interleukin-2 synthesis. J. Leukoc. Biol. 54:1993;458-464.
29. Kuo C. J., Chung J., Florentino D. F., Flanagan W. M., Blenis J., Crabtree G. R. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 358:1992;70-73.
30. Bierer B. E., Schreiber S. L., Burakoff S. J. The effect of the immunosuppressant FK506 on alternate pathways of T cell activation. Eur. J. Immunol. 21:1991;439-445.
31. Liu C. C., Joag S. V., Kwon B. S., Young J. D.-E. Induction of perforin and serine esterases in a murine cytotoxic T lymphocyte clone. J. Immunol. 144:1990;1196-1201.
32. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:1995;3806-3813.
33. Braun M. Y., Lowin B., French L., Acha-Orbea H., Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal graft-versus-host disease. J. Exp. Med. 183:1996;657-661.
34. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
35. Berke G. The CTL's kiss of death. Cell. 81:1995;9-12.
36. Cross M. J., Stewart A., Hodgkin M. N., Kerr D. J., Wakelam M. J. O. Wortmannin and its structural analogue demethoxyviridan inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 270:1995;25352-25355.
37. Ruegg U. T., Burgess G. M. Staurosporin, K-252 and UCN-01: Potent but nonspecific inhibitors of protein kinases. Trends Phamacol. Sci. 10:1989;218-220.
38. Tamaoki T. Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors. Methods Enzymol. 201:1991;340-347.
39. Emmel E. A., Verweij C. L., Durand D. B., Higgins K. M., Lacy E., Crabtree G. R. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 246:1989;1617-1620.
40. Makrigiannis A. P., Hoskin D. W. Inhibition of CTL induction by rapamycin. IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity. J. Immunol. 159:1997;4700-4707.
41. Correa M. R., Ochoa A. C., Ghosh P., Mizoguchi H., Harvey L., Longo D. L. Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J. Immunol. 158:1997;5292-5296.